Treatment with apelin increases the myocardial vascular density via upregulating SIRT3 (51) and VEGF/VEGFR2 expression (52), which also ameliorates diabetic cardiomyopathy and improves the echocardiography parameters of cardiac function. This evidence concerns the gene APLN and diabetic cardiomyopathy.